Market Research Logo

Asia-pacific Antifungal Drugs Market Forecast 2017-2025

Asia-pacific Antifungal Drugs Market Forecast 2017-2025

KEY FINDINGS
Asia Pacific antifungal drugs market is expected to grow at a CAGR of 7.01% in the forecasted period of 2017-2025. The market was calculated to be $2639 million in 2016 and is expected to hit $4880 million by 2025. Poor hygiene, developing new drug resistance are some of the factors aiding the market to grow.

MARKET INSIGHTS
Antifungal drugs market by applications is segmented by topical antifungal drugs and Oral drugs market. The antifungal drugs market segmentation by drug types is on the basis of Echinocandins market, Azoles market, Polyenes market, Allylamines, and others. It is further segmented by therapeutic indications on the basis of Aspergillosis, Dermatophytosis and Candidiasis market. Initiatives taken by the government in the healthcare policies and programs is the major factor responsible for the growth of the antifungal drugs market in Asia Pacific region. Alternate treatment options and regulatory conditions are restraining the growth of the antifungal drugs market in Asia Pacific region.

COMPETITIVE INSIGHTS
The major market players in the antifungal drugs market are Abbott Laboratories, Arbor Pharmaceuticals INC., Baxter, Astellas Pharma Inc., Bayer Healthcare, Teva Pharmaceuticals, Gilead, GlaxoSmithKline, Johnson & Johnson, Kramer Laboratories, Merck Co, Novartis and Pfizer, Sanofi-Aventis, Vertex Pharmaceuticals.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top Down Approach
2.3. Bottom Up-approach
2.4. Data Triangulation
2.5. Estimation Methodology
3. Executive Summary
3.1. Market Definition And Scope
3.2. Key Findings
4. Market Dynamics
4.1. Drivers
4.1.1. Poor Hygiene Habits
4.1.2. Development Of Drug Resistance
4.1.3. Healthcare Policies And Programs By Government
4.2. Restraints
4.2.1. Alternate Treatment Options
4.2.2. Regulatory Atmosphere
4.3. Opportunities
4.3.1. Healthcare And Related Industries Are Growing Continuously
4.3.2. Increasing Awareness And Availability Of Information
4.4. Challenges
4.4.1. Side Effects And Recurring Fungal Infections
4.4.2. Resistance To Drug
4.4.3. Rapidly Changing Technology
5. Market Segmentation
5.1. By Drug Types
5.1.1. Echinocandins Market
5.1.2. Azoles Market
5.1.3. Polyenes Market
5.1.4. Allylamines Market
5.1.5. Others Market
5.2. By Therapeutic Indications
5.2.1. Aspergillosis Market
5.2.2. Dermatophytosis Market
5.2.3. Candidiasis Market
5.2.4. Others Market
5.3. By Applications
5.3.1. Topical Antifungal Drugs Market
5.3.2. Oral Drugs Market
6. Key Analytics
6.1. Porter’s Five Force Model
6.1.1. Threat Of New Entrants
6.1.2. Threat Of Substitute Products Or Services
6.1.3. Bargaining Power Of Buyer
6.1.4. Bargaining Power Of Supplier
6.1.5. Intensity Of Competitive Rivalry
6.2. Pestel Analysis
6.3. Key Buying Criteria
6.4. Value Chain Analysis
6.5. Strategic Recommendation
6.6. Strategic Conclusions
6.7. Opportunity Matrix
6.8. Vendor Landscape
7. Geographical Analysis
7.1. Asia Pacific Antifungal Drugs Market
7.1.1. India Antifungal Drugs Market
7.1.2. China Antifungal Drugs Market
7.1.3. Japan Antifungal Drugs Market
7.1.4. Roapac Antifungal Drugs Market
8. Competitive Landscape
8.1. Market Share Analysis
8.2. Top Winning Strategies
9. Company Profiles
9.1. Abbott Laboratories.
9.1.1. Overview
9.1.2. Product Portfolio
9.1.3. Scot Analysis
9.1.4. Strategic Initiatives
9.2. Arbor Pharmaceuticals, Inc.
9.2.1. Overview
9.2.2. Product Portfolio
9.2.3. Scot Analysis
9.2.4. Strategic Initiatives
9.3. 3 Baxter
9.3.1. Overview
9.3.2. Product Portfolio
9.3.3. Scot Analysis
9.3.4. Strategic Initiatives
9.4. Astellas Pharma Inc.
9.4.1. Overview
9.4.2. Product Portfolio
9.4.3. Scot Analysis
9.4.4. Strategic Initiatives
9.5. Bayer Healthcare
9.5.1. Overview
9.5.2. Product Portfolio
9.5.3. Scot Analysis
9.5.4. Strategic Initiative
9.6. Teva Pharmaceuticals
9.6.1. Overview
9.6.2. Product Portfolio
Table List
Table # 1 Indication And Doses Of Echinocandins
Table # 2 Asia-pacific Echinocandins Market 2017-2025 ($ Million)
Table # 3 Drug Uses Of Triazoles
Table # 4 Asia-pacific Azoles Market 2017-2025 ($ Million)
Table # 5 Asia-pacific Polyenes Market 2017-2025 ($ Million)
Table # 6 Price Of Allylamine Antifungals
Table # 7 Asia-pacific Allylamines Market 2017-2025 ($ Million)
Table # 8 Asia-pacific Aspergillosis Market 2017-2025 ($ Million)
Table # 9 Common Affected Area - Dermatophytes
Table # 10 Asia-pacific Dermatophytosis Market 2017-2025 ($ Million)
Table # 11 Symptoms In The Affected Area Caused By Candidiasis
Table # 12 Asia-pacific Candidiasis Market 2017-2025 ($ Million)
Table # 13 Asia-pacific Others Market 2017-2025 ($ Million)
Table # 14 Pros And Cons Of Topical Medications
Table # 15 Brands Of Antifungal Powders And Their Functionality
Table # 16 Brands Of Antifungal Ointments And Their Functionality
Table # 17 Antifungal Pastes And Its Effect
Table # 18 Commonly Used Antifungal Drugs Dosage And Its Effects
Table # 19 Asia Pacific Antifungal Drugs Market 2017-2025 ($ Million)
Table # 20 India’s Healthcare Sector Investment
Table # 21 Companies In China Producing Antifungal Drugs
Table # 22 Total Burdens Of Fungal Infections In Japan
Figures List
Figure # 1 Healthcare Programs Initiated By The Indian Government
Figure # 2 Healthcare Industries In The World Is Rapidly Growing (%)
Figure # 3 Asia-pacific Echinocandins Market 2017-2025 ($ Million)
Figure # 4 Asia-pacific Azoles Market 2017-2025 ($ Million)
Figure # 5 Asia-pacific Polyenes Market 2017-2025 ($ Million)
Figure # 6 Asia-pacific Allylamines Market 2017-2025 ($ Million)
Figure # 7 Asia-pacific Others Market 2017-2025 ($ Million)
Figure # 8 Asia-pacific Aspergillosis Market 2017-2025 ($ Million)
Figure # 9 Asia-pacific Dermatophytosis Market 2017-2025 ($ Million)
Figure # 10 Asia-pacific Candidiasis Market 2017-2025 ($ Million)
Figure # 11 Asia-pacific Others Market 2017-2025 ($ Million)
Figure # 12 Topical Antifungal Drugs Types
Figure # 13 Asia-pacific Topical Antifungal Drugs Market 2017-2025 ($ Million)
Figure # 14 Asia-pacific Oral Drugs Market 2017-2025 ($ Million)
Figure # 15 Porter’s Five Force Model In Antifungal Drugs Market
Figure # 16 Per Capita Healthcare Expenditure In India ($)
Figure # 17 India Antifungal Drugs Market 2017-2025 ($ Million)
Figure # 18 China Antifungal Drugs Market 2017-2025 ($ Million)
Figure # 19 Japan Antifungal Drugs Market 2017-2025 ($ Million)
Figure # 20 Roapac Antifungal Drugs Market 2017-2025 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report